Description
Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies, Volume Eight, summarizes the molecular mechanisms of drug resistance in colorectal cancer, along with the most up-to-date therapeutic strategies available. The book discusses reasons why colorectal tumors become refractory during the progression of the disease, but also explains how drug resistance occurs during chemotherapy. In addition, users will find the current therapeutic strategies used by clinicians in their practice in treating colorectal cancer. The combination of conventional anticancer drugs with chemotherapy-sensitizing agents plays a pivotal role in improving the outcome of colorectal cancer patients, in particular those with drug-resistant cancer cells.From a clinical point-of-view, the content of this book provides clinicians with updated therapeutic strategies for a better choice of drugs for drug-resistant colorectal cancer patients. It will be a valuable source for cancer researchers, oncologists and several members of biomedical field who are dedicated to better treat patients with colorectal cancer.- Presents a systemic summary of molecular mechanisms for a quick and in-depth understanding- Updates current trends in the field with pioneering information on drug resistance- Encompasses both basic and clinical approaches for a better understanding of unsolved problems from a holistic point-of-view
Table of Contents
1. Drug resistence in colorectal cancer: General aspects2. Drug transporters in the development of multidrug resistance in colorectal cancer3. Role pf colorectal cancer stem cells in resistance to apoptosis and treatment in colorectal cancer4. Serrated lesions and stem cells on drug resistance and colon cancer5. Development of novel microRNA-based therapeutics platform for colorectal cancer6. Chemo-sensitizing agents for naturalorigin for colorectal cancer: Pharmacokinetics approaches7. Induction of programmed necrosis by phytochemicals in colorectal cancer8. Predictive biomarkers of drug resistance in colorectal cancer - Recent updates9. Raclb: An emerging therapeutic target for chemoresistance in colorectal cancer10. Nanotechnology-based targeted drug delivery systems and drug resistance in colorectal cancer11. Targeting colorectal cancer via nanodrug delivery systems
-
- 洋書電子書籍
-
化学の文化
Culture of…
